Imprinting at the Dlk1-Dio3 cluster is controlled by the IG-DMR, an imprinting control region differentially methylated between maternal and paternal chromosomes. The maternal IG-DMR is essential for imprinting control, functioning as a cis enhancer element. Meanwhile, DNA methylation at the paternal IG-DMR is thought to prevent enhancer activity. To explore whether suppression of enhancer activity at the methylated IG-DMR requires the transcriptional repressor TRIM28, we analyzed Trim28 chatwo embryos and performed epistatic experiments with IG-DMR deletion mutants. We found that while TRIM28 regulates the enhancer properties of the paternal IG-DMR, it also controls imprinting through other mechanisms. Additionally, we found that the paternal IG-DMR, previously deemed dispensable for imprinting, is required in certain tissues, demonstrating that imprinting is regulated in a tissue-specific manner. Using PRO-seq to analyze nascent transcription, we identified 30 novel transcribed regulatory elements, including 23 that are tissue-specific. These results demonstrate that different tissues have a distinctive regulatory landscape at the Dlk1-Dio3 cluster and provide insight into potential mechanisms of tissuespecific imprinting control. Together, our findings challenge the premise that Dlk1-Dio3 imprinting is regulated through a single mechanism and demonstrate that different tissues use distinct strategies to accomplish imprinted gene expression.
INTRODUCTION
Genomic imprinting is an epigenetic mechanism that controls the allele-specific expression of certain genes depending on their maternal or paternal inheritance. Mutations disrupting imprinted gene expression result in embryonic lethality in mice, congenital defects in humans, and affect the reprogramming of induced pluripotent stem cells, highlighting the importance of imprinting control for embryonic development and cell differentiation (1, 2) . Most imprinted genes reside in gene clusters, where their expression is controlled by imprinting control regions (ICRs), regulatory sequences that are differentially methylated between the maternally and paternally inherited chromosomes (3) . DNA methylation at these differentially methylated regions (DMRs) has been proposed to influence the allele-specific recruitment of transcription factors that function in cis to control gene expression. However, while a few proteins are known to bind certain ICRs on a methylation-dependent fashion (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) , the information to date suggests that there is not a universal mechanism of imprinting control. Instead, epigenetic marks at ICRs are interpreted in a manner that is specific for each imprinted cluster (reviewed in 3).
While most imprinted genes are expressed in an allele-specific fashion in all tissues, others show more dynamic imprinting control mechanisms. For instance, as many as 28% of all known imprinted genes display tissue-specific imprinting, with monoallelic expression in only one or a few tissues, and biallelic expression in all others (16) (17) (18) . Other genes are imprinted in a stagespecific manner, being biallelically expressed early in development and only becoming monoallelically expressed at later embryonic stages, or vice versa (19) (20) (21) . Finally, a few imprinted genes undergo imprinting reversal in a tissue-specific or stage-specific fashion, with expression from the maternal allele in some tissues or developmental stages, and from the paternal allele in others (22) (23) (24) . Despite their dynamic allele-specific expression, many genes subject to tissue and/or stage-specific imprinting still preserve the characteristic allele-specific DNA methylation at their ICRs (reviewed in 17). Therefore, either epigenetic marks at ICRs are interpreted in a context-specific fashion, or other regulatory sequences at imprinted clusters provide additional layers of tissue and stage-specific imprinting control (23, (25) (26) (27) (28) (29) (30) (31) (32) .
The Dlk1-Dio3 imprinted gene cluster contains three protein-coding genes, Dlk1, Rtl1 and Dio3, which are expressed from the paternal allele, and several non-coding RNAs, including Gtl2, Rtl1as, Rian and Mirg, that are expressed from the maternal allele as a single transcriptional unit ( Figure 1A ; reviewed in 33). The allele-specific expression of these genes is maintained in most tissues analyzed (18) . Data from mouse embryos and different human tissues has failed to provide evidence for tissue-specific imprinting of Gtl2 (18, 34) . However, Dlk1 is biallelically expressed in astrocytes (35) , shows a "relaxation" of imprinting in the liver (15% expression from the maternal allele; 36) and is subject to imprinting reversal in ESCs (24) , while Dio3 is biallelically expressed in the placenta and a few other tissues (37) . Additionally, imprinted genes in the Dlk1-Dio3 are widely expressed during embryogenesis, but the levels of expression of Gtl2 and Dlk1 are variable across tissues and developmental stages (35, (38) (39) (40) (41) (42) .
Imprinted gene expression within the Dlk1-Dio3 cluster is controlled by an InterGenic Differentially Methylated Region (IG-DMR) located between Dlk1 and Gtl2 (43) . The maternal IG-DMR is unmethylated and has been shown to be required for cis activation of maternal genes, as well as for cis repression of paternal genes in embryonic tissues (31) . A 4.15 kb deletion of the maternal IG-DMR allele in mice is embryonic lethal and causes loss of Gtl2 expression, as well as biallelic expression of Dlk1 ( Figure 1B; 31) . In contrast, the same 4.15 kb deletion of the methylated paternal IG-DMR allele does not disrupt imprinting and produces adult mice without discernible phenotypes, suggesting that the paternal IG-DMR is dispensable for imprinting control ( Figure 1C ; 31, 44) . Loss of methylation at the paternal IG-DMR causes a maternalization of the paternal chromosome, with biallelic expression of Gtl2 and biallelic repression of Dlk1 (38, 45) .
Therefore, the evidence to date indicates that the unmethylated maternal IG-DMR is functionally important to regulate imprinted gene expression in cis, while DNA methylation prevents transcriptional regulatory activity at the paternal IG-DMR. This model is further supported by recent studies identifying maternal-specific enhancer-like properties within the IG-DMR, including transcription of bidirectional short non-coding "enhancer RNAs" (eRNAs) and enhancer-specific histone modifications (24, 46, 47) , as well as interactions between the IG-DMR and the Gtl2 promoter (46) . Supporting the notion that DNA methylation abrogates the enhancer activity of the IG-DMR, the paternal methylated IG-DMR did not show enhancer-like properties in mESCs (24) .
Additionally, a recent study using a small 420bp IG-DMR deletion identified a CpG tandem repeat region within the IG-DMR that is required paternally to maintain IG-DMR methylation, but is dispensable for imprinting control when inherited maternally, suggesting that the dual roles of the IG-DMR to maintain paternal imprints and to function as a cis-enhancer element are physically separable, yet functionally connected (48) .
DNA methylation at the paternal IG-DMR is known to influence the allele-specific recruitment of certain transcriptional regulators such as ZFP57 and TRIM28, which form a transcriptional repressive protein complex (4, 45, 49) . Deletion of either Zfp57 or Trim28 during early development results in biallelic Gtl2 expression, supporting an important role for these transcription factors in regulating Dlk1-Dio3 imprinting (45, 50, 51) . Because loss of Gtl2 imprinting in maternal-zygotic Zfp57 mutants and Trim28 null embryos is accompanied by loss of DNA methylation at the paternal IG-DMR, it has been proposed that ZFP57-TRIM28 complexes regulate imprinting by maintaining methyl marks at germline DMRs during the genome-wide reprogramming events that take place shortly after fertilization (45, 50) . However, the analysis of conditional Trim28 mutants, as well as hypomorphic Trim28 chatwo embryos, showed that loss of Trim28 at later embryonic stages disrupts Gtl2 imprinting without affecting the methylation status of the IG-DMR, providing evidence that TRIM28 controls imprinting after genome-wide reprograming through molecular mechanisms that are distinct from its early role to preserve DNA methylation (50) .
To gain mechanistic insight into how gene expression is regulated at the Dlk1-Dio3 cluster, we first inquired whether TRIM28 functions after genome-wide reprogramming by binding to the methylated IG-DMR and preventing paternal IG-DMR enhancer activity. By analyzing IG-DMR RNA expression in hypomorphic Trim28 chatwo embryos and performing epistasis experiments with a deletion of the IG-DMR, we determined that TRIM28 regulates Dlk1-Dio3 imprinting after genome-wide reprogramming through mechanisms that are unrelated to its ability to bind the methylated IG-DMR. During the course of these studies, we unexpectedly found that the paternal IG-DMR, previous deemed unnecessary for imprinting control, was required to repress paternal Gtl2 expression in some embryonic tissues. Further analysis of IG-DMR deletion mutants revealed that both the maternal and paternal IG-DMRs are required for imprinting control, and that they perform different regulatory functions in a tissue-specific manner. These findings, together with results from a survey of regulatory sequences using PRO-seq, demonstrate that the control of imprinted gene expression at the Dlk1-Dio3 cluster is strikingly dynamic, comprising multiple regulatory sequences that, together with germline imprints, function in a tissue-specific manner to accomplish imprinted gene expression.
MATERIALS AND METHODS

Mice
Experiments involving IG-DMR RNA allele-specific analysis in Trim28 chatwo mutants used crosses between Trim28 chatwo mice in a congenic FvB/NJ or C57BL/6J genetic background and Trim28 chatwo mice raised in a mixed background that was predominantly FvB/NJ, but selected to be homozygous for CAST/EiJ at the Dlk1-Dio3 cluster on chromosome 12 (FvB/CAST-12).
Trim28 chatwo embryos derived from these crosses arrest at E8.5 (52) . The DIG-DMR deletion was generated in a 129/OlaHsd background (31) and maintained in a congenic C57BL/6J background.
For DIG-DMR; Trim28 chatwo epistasis experiments, DIG-DMR;Trim28 chatwo males were crossed with Trim28 chatwo mice from the mixed FvB/CAST-12 background, which generated littermate embryos of each genotype analyzed at E8.5 in Figure 2 . For experiments involving allele-specific analysis in E14.5 DIG-DMR mutants, DIG-DMR deletion males (for DIG PAT ) or females (DIG MAT ) were mated to wild type mice from the mixed FvB/CAST-12 genetic background. Genotyping primers for DIG-DMR, Trim28 chatwo and for polymorphisms at chromosome 12 are shown in Supplementary Table   1 .
Embryo collection
Embryos were dissected in ice cold phosphate buffered saline with 4% bovine serum albumin.
For analysis of individual E14.5 tissues, the yolk sac, liver, lung and limb buds were dissected from the embryo and flash-frozen in liquid nitrogen. For E8.5 embryos, the yolk sac was dissected from embryonic tissues and analyzed separately.
Expression analysis
RNA was isolated from mouse embryonic tissues using RNA-STAT60. RNA was DNase Itreated prior to First Strand cDNA synthesis using SuperScript III with random hexamer priming (Invitrogen). Expression was analyzed by quantitative reverse-transcriptase amplification (qRT-PCR) using KleenGreen (IBI). Expression was normalized to Gapdh or b-actin as indicated. The median amongst technical replicates was calculated to quantify each biological sample.
Allele specific expression was assayed by Sanger sequencing of SNP-containing RT-PCR products and quantified as the ratio of paternal:maternal expression using PeakPicker (53) . For primer sequences see Supplementary Table 1 . Statistical significance was evaluated by unpaired two-tailed Student's T-tests.
PRO-seq and dREG
Liver and yolk sac from six E14.5 embryos were flash-frozen, then broken up into a fine powder in liquid nitrogen with a pestle. Chromatin from these extracts was isolated and stored as described (http://biorxiv.org/lookup/doi/10.1101/185991). Precision Nuclear Run-On was performed on chromatin samples and then processed for sequencing as described (54) . PROseq was performed on two replicates for each tissue. Samples were obtained from embryos containing parent-of-origin polymorphisms at the Dlk1-Gtl2 locus on Chr. 12 (C57BL/6J, maternal;
CAST/EiJ, paternal). dREG was performed as previously described (55) on each PRO-seq dataset. Only common dREG peaks between replicates were considered. A validation of dREG results was performed by comparing identified peaks with ENCODE ChIP data on histone marks characteristic of enhancers (H3K27ac and H3K4me1) and promoters (H3K27ac and H3K4me3). Figure 6 for details. PRO-seq data was deposited in the NCBI GEO database under the accession number GSE119882.
See Supplementary
RESULTS
The paternal IG-DMR displays enhancer-like properties in Trim28 hypomorphic mutants.
Our previous analysis showed that TRIM28 controls genomic imprinting through distinct mechanisms during and after genome-wide reprogramming. Specifically, we found that conditional Trim28 mutants and hypomorphic Trim28 chatwo embryos had biallelic Gtl2 expression without affecting IG-DMR methylation, providing evidence that TRIM28 functions through mechanisms that are distinct from its early role maintaining DNA methylation at germline imprints during genome-wide reprogramming (50) . To investigate the mechanisms used by TRIM28 to control imprinting after genome-wide reprogramming, we first tested whether TRIM28 regulates the enhancer properties of the IG-DMR. To this end, we analyzed E8.5 embryos homozygous for the Trim28 chatwo allele, a condition that decreases the transcriptional repressive activity and protein stability of TRIM28 (52) , and used expression of RNA from the IG-DMR (hereby called IG-DMR RNAs) as a proxy for enhancer activity (24, (56) (57) (58) . Because previous studies showing IG-DMR RNA expression were performed in mESCs (24), we first sought to confirm whether maternalspecific enhancer-like transcription could be observed in embryonic samples. To measure transcription from the IG-DMR, we performed qRT-PCR, using embryos with a maternal 4.15 kb IG-DMR deletion (DIG MAT ; 31) as negative controls. We found that IG-DMR RNA was expressed in E8.5 wild type embryos at very low levels with respect to Gapdh, but that these levels were statistically different compared to negative control DIG MAT embryos ( Figure 1D , p < 0.0003). This result provides evidence that, similar to mESCs, IG-DMR RNAs are transcribed from the maternal allele in E8.5 embryos. To further confirm that embryonic IG-DMR RNA expression is maternalspecific, we sequenced RT-PCR products from E8.5 embryos that contained single nucleotide polymorphisms (SNPs) distinguishing the maternal and paternal alleles. We found that the paternal-to-maternal IG-DMR RNA allele expression ratios in individual E8.5 wild type embryos were very low ( Figure 1E ), demonstrating that IG-DMR RNAs are primarily expressed from the maternal allele. In contrast, analysis of allele-specific expression in Trim28 chatwo embryos showed a significant number of embryos with high levels of IG-DMR RNA biallelic expression ( Figure 1E ), supporting a role for TRIM28 in repressing IG-DMR RNA expression from the paternal allele.
Because Trim28 chatwo embryos have wild type levels of DNA methylation at the IG-DMR (50), our findings suggest that TRIM28 regulates genomic imprinting after genome-wide reprogramming by preventing IG-DMR enhancer activity from the methylated IG-DMR.
TRIM28 controls Gtl2 imprinted expression through mechanisms other than binding the paternal IG-DMR.
Our analysis of IG-DMR transcription in Trim28 chatwo mutants showed variable levels of biallelic
IG-DMR RNA expression between individual E8.5 embryos, with 14/28 Trim28 chatwo mutants
showing maternal-specific IG-DMR RNA expression and 14/28 others showing expression from both the maternal and paternal allele ( Figure 1E ). This partially-penetrant biallelic expression from the IG-DMR was reminiscent of the partially penetrant loss of Gtl2 imprinting that we previously observed in Trim28 chatwo mutants (50) . To determine if biallelic expression of Gtl2 in Trim28 chatwo embryos could be explained by abnormal paternal IG-DMR enhancer activity, we measured IG-DMR RNA and Gtl2 biallelic expression in single Trim28 chatwo mutants. We found that all the Trim28 chatwo embryos that biallelically expressed IG-DMR RNA also showed Gtl2 biallelic expression ( Figure 1F ). However, the degree of biallelic Gtl2 expression in these Trim28 chatwo mutants did not correlate with the levels of IG-DMR RNA transcription. Additionally, many
Trim28 chatwo embryos showed biallelic Gtl2 expression without biallelically expressing IG-DMR RNA. Therefore, while aberrant enhancer-like transcription at the paternal IG-DMR could contribute to Trim28 chatwo imprinting defects, this ectopic enhancer-like activity cannot fully explain loss of Gtl2 imprinting in Trim28 chatwo mutants.
Previous studies suggest that TRIM28 regulates imprinting by binding to the methylated paternal IG-DMR (4). However, given that neither loss of IG-DMR DNA methylation (50), nor paternal IG-DMR enhancer-like activity ( Figure 1F ) can fully explain loss of imprinting in Trim28 chatwo mutants, we hypothesized that TRIM28 might regulate Gtl2 through alternative mechanisms that do not require TRIM28 binding to the paternal IG-DMR. To test this hypothesis, we performed epistasis experiments between Trim28 chatwo mutants and mutants with the 4.15 kb deletion of the paternal IG-DMR (DIG PAT ; 31). If TRIM28 controls imprinting at Gtl2 solely by binding the paternal IG-DMR, we would expect the paternal IG-DMR deletion to be epistatic over loss of Trim28. In this scenario, DIG PAT ;Trim28 chatwo mutants would show maternal-specific expression of Gtl2, as previously reported for DIG PAT mutants ( Figure 1C; 31) . In contrast to this expectation, we observed that DIG PAT ;Trim28 chatwo embryos expressed Gtl2 biallelically and at similar levels to those found in Trim28 chatwo mutants (Figure 2 , columns 3-4), revealing that the Trim28 chatwo mutation is epistatic over deletion of the paternal IG-DMR. These findings demonstrate that, to maintain proper Gtl2 imprinting, TRIM28 must function by binding sequences other than the paternal IG-DMR.
The paternal IG-DMR has tissue-specific requirements for imprinted gene expression.
Deletion of the paternal IG-DMR has been previously shown to be dispensable for imprinting control in whole E16 embryos ( Figure 1C; 31 ). Intriguingly, however, our analysis of DIG PAT E8.5 embryos showed that although these mutants expressed Gtl2 primarily from the maternal allele, there was a slight expression of paternal Gtl2 compared to wild type littermates ( Figure 2 Analysis of Dlk1-Dio3 imprinting in the E14.5 liver did not show any significant effects for the paternal IG-DMR deletion on either the expression of maternally-expressed Gtl2, or paternallyexpressed Dlk1 and Dio3 ( Figure 3A) . Additionally, analysis of allele-specific expression of Gtl2
using Sanger sequencing revealed that in wild type liver samples Gtl2 was exclusively expressed from the maternal allele and that there were no statistically significant differences in DIG PAT mutants ( Figure 3C , wt n=6, DIG PAT n=7). Therefore, the paternal IG-DMR is not required to regulate Gtl2 expression in cis and is dispensable for imprinting control in the liver.
In contrast, we found that the paternal IG-DMR was required for imprinting control in the E14.5 yolk sac. In E14.5 yolk sacs from DIG PAT mutants, Dlk1 and Dio3 expression levels were normal, but Gtl2 expression was elevated compared to wild type littermate controls ( Figure 3B ), suggesting that the paternal IG-DMR is required for cis repression of Gtl2 in the yolk sac. To further test a possible tissue-specific role of the paternal IG-DMR as a repressive cis regulatory element, we measured allelic expression of Gtl2 in DIG PAT samples. In contrast with liver, lung and limb tissues, where the DIG PAT mutation did not have drastic effects on Gtl2 allele-specific expression, we found that deletion of the paternal IG-DMR in E14.5 yolk sacs resulted in complete loss of Gtl2 imprinting, with equal levels of Gtl2 expression from the maternal and paternal alleles ( Figure 3C , column 4, p < 0.005, wt n=6, DIG PAT n=7). Therefore, our results show that the paternal IG-DMR is essential for silencing paternal Gtl2 specifically in the yolk sac.
Overall, our analysis of DIG PAT mutants demonstrates novel functions of the paternal IG-DMR and reveals that this regulatory sequence is required for imprinting control in a tissue-specific manner.
Tissue-specific requirements for the maternal IG-DMR.
A previous study showed that deletion of the maternal IG-DMR has different effects on Dlk1-Dio3 imprinted gene expression in E16 placentas, as compared with their respective embryonic samples. Specifically, the maternal IG-DMR, which is required in embryos for expression of both maternally and paternally expressed genes in the Dlk1-Dio3 cluster ( Figure 1B; 31) , was found to be dispensable for Gtl2 expression in DIG MAT placentas (44) . These findings prompted us to evaluate whether the maternal IG-DMR also has specific requirements in other tissues. To this end, we analyzed Dlk1-Dio3 gene expression by qRT-PCR in the yolk sac and liver of DIG MAT mutants.
We found that the maternal IG-DMR was required for repression of Dlk1 in both E14.5 liver and yolk sac tissues (Figure 4) , a result consistent with the previous analysis of DIG MAT mutants ( Figure 1B; 31, 44 ). However, while our experiments showed a loss of Gtl2 expression in DIG MAT liver samples ( Figure 4A , p = 0.029, wt n=3, DIG MAT n=5), Gtl2 expression was not significantly altered in DIG MAT yolk sac tissues ( Figure 4B , wt n=4, DIG MAT n=4). Thus, our analysis of DIG MAT mutants provides additional evidence for the tissue-specific roles of the maternal IG-DMR, revealing that this sequence is dispensable for Gtl2 activation in the yolk sac.
The Dlk1-Dio3 imprinted cluster contains tissue-specific transcribed regulatory elements.
Our findings that both the paternal and maternal IG-DMRs are required to control imprinted gene expression in a tissue-specific manner suggests that this regulatory sequence is interpreted in different ways depending on the tissue context. Notably, our analysis shows that the tissuespecific regulation of Gtl2 expression by the IG-DMR does not result in tissue-specific imprinting, since Gtl2 was expressed exclusively from the maternal allele in all tissues analyzed ( Figure 3C;   18 ). Consequently, our results highlight that allele-specific transcriptional control is likely achieved through different mechanisms and regulatory sequences in different tissues. Specifically, our data show that deletion of the paternal IG-DMR has little effect on Gtl2 expression in liver samples, but causes biallelic expression of Gtl2 in the yolk sac, indicating that this sequence is required to repress Gtl2 specifically in this tissue ( Figure 6 ). Conversely, the maternal IG-DMR functions as an enhancer for Gtl2 in liver tissues, but it is dispensable for Gtl2 expression in the yolk sac ( Figure 6 ), suggesting that additional regulatory sequences control transcription of Gtl2 in this extraembryonic membrane.
To gain a better understanding of the regulatory landscape of the Dlk1-Dio3 imprinted cluster, we quantified nascent transcription in tissues using RNA pol II Precision Run-On and sequencing (59) on isolated chromatin (http://biorxiv.org/lookup/doi/10.1101/185991). Because our goal was to identify tissue-specific regulatory elements that could function in cis to regulate allele-specific expression of Dlk1-Dio3 imprinted genes, we performed PRO-seq on tissue samples harboring SNPs between the maternal (C57BL/6J) and paternal (CAST/EiJ) alleles at the Dlk1-Dio3 cluster.
PRO-seq data was analyzed through dREG, a machine-learning algorithm that identifies transcribed regulatory elements (TRE), including enhancers and promoters (55) . Data quality analysis, including assessment of the number of sequence reads, overlap of dREG results in biological replicates, as well was the overlap of dREG peaks with enhancers and promoters (as defined by H3K27ac, H3K4me1 and H3K4me3 in ENCODE E14.5 liver datasets) is shown in Supplementary Figure 6 .
PRO-seq and dREG analysis of E14.5 liver and yolk sac samples identified a total of 36 TREs within the Dlk1-Dio3 imprinted cluster ( Supplementary Figure 2 ). 11 TREs were common between the yolk sac and liver, 21 TREs were unique to yolk sac, and 4 TREs were unique to liver. Among the 36 identified TREs were the promoters of Dlk1, Gtl2, and Dio3, (found in both liver and yolk sac: peaks 10, 21, and 36 in Supplementary Figure 2B ), the Rtl1 promoter (found only in the liver: peak 22 in Supplementary Figure 2B) , and promoters for two expressed sequence tags (ESTs, GenBank CB951180 and BU055945; Supplementary Figure 2B , peaks 23 and 29, respectively). Figure 5A, Supplementary Figure 4B ).
The remaining 30 TREs showed bidirectional transcription without elongation (Supplementary
In summary, our PRO-seq analysis identified 30 novel putative regulatory regions at the Dlk1-Dio3 cluster, and demonstrates that the liver and yolk sac have distinct transcriptional regulatory landscapes.
PRO-seq reveals tissue-specific transcriptional activity at the IG-DMR.
During our analysis, we noticed that the IG-DMR showed a different PRO-seq profile in the liver as compared to the yolk sac ( Figure 5A, peak 16 ). In fact, dREG analysis identified peak 16 as a liver-specific TRE, a discovery consistent with our findings that the maternal IG-DMR is essential for activation of Gtl2 in the liver, but not in the yolk sac. These observations suggest that the IG-DMR might contain several independent regulatory sequences with tissue-specific functions. To further explore this possibility, we compared our PRO-seq findings with a published analysis of nascent transcription in mESCs using genome-wide nuclear run-on (GRO-seq; 60). This comparison revealed that mESCs have a distinct TRE profile, with nascent transcription located at different IG-DMR coordinates than those we observed in liver or yolk sac samples ( Figure 5A ). Together, these observations suggest that the IG-DMR contains distinct regulatory sequences that operate in different developmental contexts.
PRO-seq identifies a maternal-specific TRE in yolk sac tissues.
To determine whether the our PRO-seq and dREG datasets could identify novel TREs responsible for tissue-specific imprinting control, we searched for TREs that were expressed in an allele-specific manner by quantifying the number of PRO-seq reads containing maternal or paternal SNPs. Of the 36 TREs identified within the Dlk1-Dio3 cluster, 25 contained annotated SNPs (Supplementary Figure 2B) . The majority of these TREs (20 TREs) showed expression from both parental alleles, but 5 TREs (peaks 10, 19, 20, 21, and 22) showed monoallelic expression. We found that 3 of these 5 monoallelic TREs correspond to loci expected to have monoallelic activity, including the Dlk1 promoter (peak 10, paternally expressed), the Gtl2 promoter (peak 21, maternally expressed) and the Rtl1 promoter (peak 22, paternally expressed).
Interestingly, the other two monoallelic TREs mapped near the Gtl2 promoter, in regions not previously described to contain regulatory elements (peaks 19 and 20, 5kb and 1kb from the Gtl2 promoter, respectively). One of these TREs was expressed in both liver and yolk sac (peak 20), while the other one (peak 19, hereafter called TRE19) was yolk sac-specific ( Figure 5A ). While further experiments will be required to confirm whether TRE19 regulates allele-specific expression in yolk sac tissues, these results support PRO-seq as a valuable tool to identify novel regulatory regions within imprinted clusters.
Sequence conservation suggests functional relevance of TREs for imprinting control.
To assess whether the TREs identified in our PRO-seq datasets might be functionally significant, we examined the sequence conservation at the Dlk1-Gtl2 intergenic region across several placental mammals. Interestingly, this analysis revealed that many of the TREs identified in our studies were located in areas of high sequence conservation amongst species ( Figure 5C ).
Notably, the yolk sac-specific TRE19, TRE20, as well as the liver-specific TRE18 were all highly conserved, as was the region of the IG-DMR that shows mESC-specific nascent transcription.
The conservation plot also revealed areas of high conservation that do not contain TREs in our dataset, nor nascent transcription in mESCs (60) . These conserved regions could correspond to TREs that are only active in other tissues, or to repressive regulatory elements, which are not identified by nascent transcription. The fact that some of the TREs identified in our study are conserved across evolution suggests that these regions have critical regulatory functions and validates nascent transcription as a powerful tool to unravel the regulatory mechanisms that control imprinted gene expression.
DISCUSSION
Our results demonstrate that imprinted gene expression at the Dlk1-Dio3 cluster is regulated by an intricate transcriptional regulatory landscape, involving multiple regulatory sequences that are interpreted in a tissue-specific fashion. By investigating the functions of the IG-DMR in early embryos, liver and yolk sac, we uncovered distinct requirements for both the maternal and paternal IG-DMRs in each of these settings. Additionally, our analysis of nascent transcription identified 30 novel regions containing potential regulatory elements, some of which display tissuespecific activity. These results, together with our discovery that TRIM28 operates both at the IG-DMR and at additional regulatory sequences, challenge the view that imprinted gene expression at an individual imprinted cluster is regulated through a single mechanism across tissue types and embryonic stages. Instead, our findings reveal that multiple regulatory sequences cooperate to regulate imprinted gene expression in a tissue-specific fashion.
After genome-wide reprogramming, TRIM28 controls imprinting through regulatory regions other than the IG-DMR.
Our previous analysis of Trim28 conditional mutants and hypomorphic Trim28 chatwo embryos revealed that TRIM28 influences imprinted gene expression after genome-wide reprogramming through mechanisms that do not involve the maintenance of DNA methyl marks at the IG-DMR (50) . Because TRIM28 has been described to bind to the methylated IG-DMR in mESCs (4), we investigated whether TRIM28 functions by binding the methylated paternal IG-DMR and preventing enhancer activity from this sequence. While our results show that loss of TRIM28 function causes biallelic expression of IG-DMR RNAs, our data indicate that this effect cannot fully explain the imprinting defects of Trim28 chatwo embryos. Furthermore, epistasis experiments between Trim28 chatwo and DIG PAT mutants indicate that TRIM28 controls imprinting after genomewide reprogramming by mechanisms that do not involve binding to the paternal IG-DMR.
Consequently, our results suggest that TRIM28 binds to additional regulatory regions to regulate imprinting. Published ChIP-seq experiments in ESCs have not revealed any TRIM28 binding regions at the Dlk1-Dio3 cluster other than the IG-DMR (4). Nonetheless, since this published study was performed in mESCs, we cannot exclude the possibility that TRIM28 binds to other regions in different cell types. The DNA target specificity of TRIM28 has been ascribed to its ability to interact with members of the KRAB zinc finger protein family (KRAB-ZFP; 61) and a recent ChIP-exo survey of human KRAB-ZFPs in 293T cells identified several KRAB-ZFPs that bind near Gtl2 (62) . Of the 228 human KRAB-ZFPs reported in this study, 8 showed binding within 2kb of the Gtl2 promoter (ZNF445, ZNF793, ZFP57, ZNF2, ZNF28, ZNF383, ZNF684, ZNF468), 4 bound 13kb upstream of Gtl2 near the IG-DMR (ZNF257, ZNF528, ZNF445, ZNF429), and one 6kb upstream of Gtl2 (ZNF780A) ( Supplementary Figure 5) . Although the results from this ChIPexo study correspond to human KRAB-ZFPs and remain to be validated, this analysis offers several candidate locations other than the IG-DMR where TRIM28 could bind to regulate imprinting. While further studies will be needed to elucidate the mechanisms by which TRIM28 controls imprinting after genome-wide reprogramming, our data demonstrates that TRIM28 functions through mechanisms that do not involve IG-DMR binding. This finding underscores our conclusion that multiple regulatory sequences are responsible for proper imprinting control.
Dlk1-Dio3 imprinting requires both maternal and paternal IG-DMRs in a tissue-specific fashion.
Previous studies determined that deletion of the 4.15 kb paternal IG-DMR is dispensable for imprinting control ( Figure 1C; 31, 44 ). However, our experiments in early embryos and embryonic tissues demonstrate that both the maternal and the paternal alleles of this 4.15 kb IG-DMR sequence are required to control imprinted gene expression. We presume that effects of the paternal 4.15 kb IG-DMR deletion could have been undetected in previous studies due to differences in the sensitivity of the assays used (Northern blot in ref 31; qRT-PCR in our study) or because of differences between the tissues and stages analyzed (whole E16 embryos in ref 31; individual E14.5 tissues and E8.5 embryos in our study). Interestingly, our results show that deletion of the IG-DMR has different effects in different tissues, as well as on specific imprinted genes. For instance, we show that deletion of the maternal IG-DMR has effects on Dlk1 and Gtl2 expression in E14.5 liver, but only disrupts Dlk1 imprinting in E14.5 yolk sac. These tissue-specific requirements are consistent with those previously described for the maternal IG-DMR in embryonic versus placental tissues (44) . Specifically, Lin et al. found that the maternal IG-DMR controls Dlk1 imprinting in both E16 embryonic and placental tissues, but is only required for Gtl2 expression in embryos and not in placentas, a tissue subject to similar imprinting control as the yolk sac (36, 63) . Our results expand these observations by providing evidence that deletion of the paternal IG-DMR also has different effects in different tissues. Namely, we find that the paternal IG-DMR controls Gtl2 expression in the yolk sac, but not in the liver (Figure 6B-C) .
Notably, while the 4.15 kb maternal IG-DMR deletion is embryonic lethal by E16, paternal IG-DMR deletion mutants are viable and fertile (31) . The fact that imprinting defects in DIG PAT mutants are compatible with embryonic survival is likely due to the tissue-specific effects of this regulatory sequence and highlights that some tissues can tolerate differences in the total amount of Dlk1, Dio3 and Gtl2.
Tissue-specific imprinting effects have been previously described for some of the genes at the Dlk1-Dio3 cluster. Dlk1 shows biallelic expression in astrocytes (35) , a relaxation of imprinting in the liver (36) and imprinting reversal in ESCs (24) , while Dio3 is biallelically expressed in several tissues (37) . Additionally, the levels of expression of these genes are variable across tissues and developmental stages. For instance, Dlk1 is expressed at high levels in many embryonic and extraembryonic tissues, including lung and liver, while expression is downregulated in most adult tissues postnatally (34) . Also worth considering is the fact that all genes in the cluster are not expressed simultaneously in the same tissues and/or developmental stages (34, 40) , arguing that expression of each gene in the Dlk1-Dio3 cluster is regulated by separate regulatory sequences (64) . Here, we show that expression of Gtl2, which is not known to be subject to tissue-imprinting effects (18, 34) and is expressed from the maternal allele in all the tissues we analyzed ( Figure   3C ), is disrupted by deletion of either the maternal or paternal IG-DMRs in a tissue-specific fashion. Therefore, our findings provide evidence that imprinted maternal Gtl2 expression is regulated by distinct mechanisms and regulatory sequences in different tissues.
The IG-DMR has tissue-specific regulatory functions.
By showing that the deletion of either the maternal or paternal IG-DMRs has different tissuespecific effects on Dlk1, Dio3 and Gtl2 expression, our results demonstrate that the IG-DMR regulates imprinting through different molecular mechanisms. Tissue-specific requirements for the germline DMR have been previously described for other imprinted clusters, including the Igf2-H19 loci (65) (66) (67) (68) . In this case, tissue-specific effects of ICR deletions have been partially attributed to tissue-specific regulatory elements that reside within the ICR, to tissue-specific modifications in the transcription factors known to bind the ICR, or to disruptions in the long range chromatin interactions that take place between tissue-specific enhancers, intergenic silencers and gene promoters (65, 68) . Although these general mechanisms might also help explain the tissuespecific imprinting effects caused by deletion of the IG-DMR, findings at the H19-Igf2 locus are difficult to extrapolate, given the drastic differences in imprinting control between these two imprinted clusters. For instance, the maternal unmethylated ICR at the H19-Igf2 loci binds the chromatin insulator CCCTC-binding factor (CTCF) and functions as a boundary element that restricts the cis interaction of shared mesoderm and endoderm enhancers with the Igf2 promoter (6, 8) . However, CTCF binding or insulator activity have not been described to play major roles in regulating Dlk1-Gtl2 imprinting (7) and expression of Dlk1 and Gtl2 is for the most part controlled by independent regulatory elements, rather than common enhancers (64) .
While our data cannot exclude the possibility that, similar to the H19-Igf2 cluster, some of the tissue-specific effects of the IG-DMR deletion might be the consequence of long-range disruptions in chromatin conformation, our results provide support for the hypothesis that the regulatory sequences located at the IG-DMR are interpreted in a tissue-specific fashion. In particular, we found that the PRO-seq profile of the IG-DMR is different between E14.5 liver, E14.5 yolk sac and a previous GRO-seq study performed in mESCs (60) . Interestingly, this GRO-seq study shows mESC-specific enhancer activity at the 3'end of the IG-DMR, in an area where the transcriptional regulators AFF3 and ZFP281 have been described to bind the IG-DMR and regulate IG-DMR RNA expression ( Figure 5B; 47, 69 ). Together, these findings suggest that within the IG-DMR, as defined by the 4.15 kb deleted in DIG mutants (31) , there are several regulatory sequences with the ability to recruit a variety of transcription factors, some of which are likely expressed only in certain cell types.
Multiple regulatory sequences are required for proper imprinting control.
By showing that TRIM28 controls imprinting through regulatory sequences other than the IG-DMR, and that the maternal IG-DMR is dispensable for Gtl2 expression in the yolk sac, our results provide evidence that multiple regulatory sequences are required for proper imprinting control at the Dlk1-Dio3 cluster. Therefore, the identification of these regulatory sequences is critical to achieve a better understanding of the mechanisms of imprinting control at this locus. Analysis of transgenic mice bearing bacterial artificial chromosomes (BACs) has provided some clues about the location of regulatory sequences. These studies show that enhancers for expression of Gtl2 in embryo, placenta and adult brain are localized within a BAC transgene spanning from 3.5kb upstream of Dlk1 to 59 kb downstream of Gtl2 (34) , and that most of the regulatory sequences for Dlk1 are located in the region contained from 41 kb upstream to 36 kb downstream of the Dlk1 coding region (64, 70) . While these studies provide evidence that tissue-specific regulation of Dlk1 and Gtl2 relies on separate regulatory elements, the precise location of all tissue-specific enhancers, as well as the mechanisms by which these sequences coordinate with the IG-DMR to ensure allele-specific expression remain to be discovered. By using PRO-seq and dREG to compare nascent transcription between E14.5 liver and yolk sac tissues, we identified 30 novel TREs at the Dlk1-Gtl2 cluster. Although more experiments will be needed to confirm the regulatory roles of these regions, our finding that many TREs map to areas of high evolutionary conservation across mammalian species suggest that they have critical regulatory functions.
In conclusion, our results demonstrate that gene expression at the Dlk1-Dio3 cluster is controlled by multiple regulatory sequences that exert imprinting control in a tissue-specific manner. Additionally, our analysis of nascent transcription highlights the power of this technique to uncover the regulatory mechanisms that control imprinted gene expression. 
